Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications
Frontiers in Immunology · 2026
DOI: 10.3389/fimmu.2026.1753611 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, 2026. Verfasst von Yunbing Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Northern Jiangsu People's Hospital, Yangzhou, China. Hauptthemen laut MEDLINE: Exosomes, Autoimmune Diseases, RNA, Untranslated. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Autoimmune diseases (ADs) are typically characterized by the immune system erroneously targeting self-organs and tissues, leading to chronic inflammation and organic damage. Current therapeutic strategies, which largely focus on suppressing late-stage inflammation, often fail to achieve satisfactory long-term outcomes. Exosomes, nanoscale extracellular vesicles secreted by diverse cell types, play a pivotal role in intercellular communication and immune regulation through the transfer of bioactive molecules, including non-coding RNAs (ncRNAs). Accumulating evidence indicates that exosomal ncRNAs, primarily microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), have emerged as critical regulators in the pathogenesis of ADs. They modulate key processes such as immune regulation, oxidative stress, autophagy and the cell cycle. In this review, we summarize recent advances in the regulatory mechanisms of exosomal ncRNAs in autoimmune diseases, with specific emphasis on Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), Type 1 Diabetes Mellitus (T1DM), Inflammatory Bowel Disease (IBD), and Sjögren’s Syndrome (SS). We also highlight their potential as diagnostic biomarkers and therapeutic targets. Finally, we discuss current challenges limiting clinical translation, such as delivery efficiency, stability, immunogenicity and large-scale validation, and propose future directions for the development of precision medicine strategies in autoimmune diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Northern Jiangsu People's Hospital, Yangzhou, China.
- Center of Molecular Diagnostic, Northern Jiangsu People's Hospital, Yangzhou, China.
- Medical Research Center, Northern Jiangsu People's Hospital, Yangzhou, China.
- Department of Laboratory Medicine, School of Medicine, Jiangsu University, Zhenjiang, China.
- Department of Prenatal Diagnosis, Center of Medical Genetics, Yancheng Maternal and Child Health Care Hospital Affiliated to Jiangsu Medical College, Yancheng, China.
Zitieren
APA
Wu, Y., Li, X., Jin, Y., Mao, F., & Zhang, L. (2026). Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1753611
Vancouver
Wu Y, Li X, Jin Y, Mao F, Zhang L. Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications. Frontiers in Immunology. 2026. doi:10.3389/fimmu.2026.1753611
BibTeX
@article{Wu2026,
author = {Wu, Yunbing and Li, Xia and Jin, Yue and Mao, Fei and Zhang, Lu},
title = {Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications},
journal = {Frontiers in Immunology},
year = {2026},
doi = {10.3389/fimmu.2026.1753611}
}
EUVIMED